Last reviewed · How we verify
Drug Cocktail
Drug Cocktail is a Small molecule drug developed by Eli Lilly and Company. It is currently in Phase 1 development. Also known as: Caffeine + Warfarin (plus vitamin K) + Omeprazole + Dextromethorphan + Midazolam, Caffeine + Warfarin + Dextromethorphan + Midazolam.
At a glance
| Generic name | Drug Cocktail |
|---|---|
| Also known as | Caffeine + Warfarin (plus vitamin K) + Omeprazole + Dextromethorphan + Midazolam, Caffeine + Warfarin + Dextromethorphan + Midazolam |
| Sponsor | Eli Lilly and Company |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Drug Cocktail CI brief — competitive landscape report
- Drug Cocktail updates RSS · CI watch RSS
- Eli Lilly and Company portfolio CI
Frequently asked questions about Drug Cocktail
What is Drug Cocktail?
Drug Cocktail is a Small molecule drug developed by Eli Lilly and Company.
Who makes Drug Cocktail?
Drug Cocktail is developed by Eli Lilly and Company (see full Eli Lilly and Company pipeline at /company/eli-lilly).
Is Drug Cocktail also known as anything else?
Drug Cocktail is also known as Caffeine + Warfarin (plus vitamin K) + Omeprazole + Dextromethorphan + Midazolam, Caffeine + Warfarin + Dextromethorphan + Midazolam.
What development phase is Drug Cocktail in?
Drug Cocktail is in Phase 1.
Related
- Manufacturer: Eli Lilly and Company — full pipeline
- Also known as: Caffeine + Warfarin (plus vitamin K) + Omeprazole + Dextromethorphan + Midazolam, Caffeine + Warfarin + Dextromethorphan + Midazolam
- Compare: Drug Cocktail vs similar drugs
- Pricing: Drug Cocktail cost, discount & access